Aurora Daljit Singh: insider trades.
Aurora Daljit Singh reported 27 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 11 sales ($701K), across 1 company.
- Transactions
- 27
- Purchases (P)
- 0
- Sales (S)
- 11
- Companies
- 1
- Name as filed
- Aurora Daljit Singh
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | Officer · See Remarks | 27 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-21 | Neumora Therapeutics, Inc. | M | 20,553 | $0.72 | 69,303 | Form 4 |
| 2026-08-21 | Neumora Therapeutics, Inc. | S | 20,553 | $1.59 | 48,750 | Form 4 |
| 2026-08-21 | Neumora Therapeutics, Inc. | S | 21,055 | $1.6 | 0 | Form 4 |
| 2026-08-21 | Neumora Therapeutics, Inc. | M | 21,055 | $0.72 | 21,055 | Form 4 |
| 2026-08-20 | Neumora Therapeutics, Inc. | M | 67,741 | $0.72 | 116,491 | Form 4 |
| 2026-08-20 | Neumora Therapeutics, Inc. | S | 66,711 | $1.51 | 0 | Form 4 |
| 2026-08-20 | Neumora Therapeutics, Inc. | M | 45,026 | $0.72 | 66,711 | Form 4 |
| 2026-08-20 | Neumora Therapeutics, Inc. | M | 21,685 | $0.72 | 21,685 | Form 4 |
| 2026-08-20 | Neumora Therapeutics, Inc. | S | 67,741 | $1.51 | 48,750 | Form 4 |
| 2026-08-19 | Neumora Therapeutics, Inc. | S | 30,918 | $1.65 | 0 | Form 4 |
| 2026-08-19 | Neumora Therapeutics, Inc. | M | 30,918 | $0.72 | 30,918 | Form 4 |
| 2026-08-19 | Neumora Therapeutics, Inc. | S | 31,000 | $1.65 | 48,750 | Form 4 |
| 2026-08-19 | Neumora Therapeutics, Inc. | M | 17,732 | $0.72 | 79,750 | Form 4 |
| 2026-08-19 | Neumora Therapeutics, Inc. | M | 13,268 | $0.72 | 62,018 | Form 4 |
| 2026-08-18 | Neumora Therapeutics, Inc. | S | 34,987 | $1.59 | 0 | Form 4 |
| 2026-08-18 | Neumora Therapeutics, Inc. | M | 34,987 | $0.72 | 34,987 | Form 4 |
| 2026-08-18 | Neumora Therapeutics, Inc. | S | 34,162 | $1.58 | 48,750 | Form 4 |
| 2026-08-18 | Neumora Therapeutics, Inc. | M | 34,162 | $0.72 | 82,912 | Form 4 |
| 2026-08-17 | Neumora Therapeutics, Inc. | M | 40,890 | $0.72 | 123,660 | Form 4 |
| 2026-08-17 | Neumora Therapeutics, Inc. | M | 15,355 | $0.72 | 139,015 | Form 4 |
| 2026-08-17 | Neumora Therapeutics, Inc. | S | 55,016 | $1.5 | 0 | Form 4 |
| 2026-08-17 | Neumora Therapeutics, Inc. | M | 29,737 | $0.72 | 55,016 | Form 4 |
| 2026-08-17 | Neumora Therapeutics, Inc. | M | 25,279 | $0.72 | 25,279 | Form 4 |
| 2026-08-17 | Neumora Therapeutics, Inc. | M | 1,424 | $0.72 | 140,439 | Form 4 |
| 2026-08-17 | Neumora Therapeutics, Inc. | S | 57,670 | $1.51 | 82,770 | Form 4 |
| 2026-08-17 | Neumora Therapeutics, Inc. | S | 34,020 | $1.49 | 48,750 | Form 4 |
| 2026-08-17 | Neumora Therapeutics, Inc. | M | 1 | $0.72 | 140,440 | Form 4 |
Questions
What stock did Aurora Daljit Singh buy or sell?
Aurora Daljit Singh reported 27 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 11 sales ($701K), across 1 company.
Is Aurora Daljit Singh the same person as other filers with this name?
This page covers SEC CIK 1793971 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/aurora-daljit-singh-1793971.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.